Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Schizophrenia
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Schizophrenia
    TopAbstracts in Schizophrenia 10/02/2008 - (DGNews)
    TopAbstracts in Schizophrenia 09/18/2008 - (DGNews)
    Newer Antipsychotics No Better Than Older Ones in Treating Child, Adolescent Schizophrenia - (DGNews)
    Majority of Patients With Schizophrenia Remain Marginalised Even After Recovery: Presented at CPA - (DGDispatch)
    TopAbstracts in Schizophrenia 09/04/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Schizophrenia

    Webcasts/CME archive

     Recent cases - Schizophrenia
      Diabetic Control and Atypical Antipsychotics: A Case Report
      A Familial Concurrence of Schizophrenia and Gaucher's Disease
      Necrotising Colitis Related to Clozapine? A Rare but Life Threatening Side Effect
      Case Report: Psychosis in an Adolescent with Sickle Cell Disease
      Case Report: Rapidly Fatal Bowel Ischaemia on Clozapine Treatment

      Cases archive
        




      my personal edition > schizophrenia > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Possible Genetic Linkage Cited in Antipsychotic Drug Weight Gain

      Lancet

      06/13/2002
      By Harvey McConnell


      There appears to be a genetic basis for the weight gain associated with use of antipsychotic drugs among patients with schizophrenia.

      Dr. Gavin Reynolds and colleagues at the Department of Biomedical Science, University of Sheffield, Sheffield, England, carried out their research because increased body fat is a side-effect of treatment with antipsychotic drugs for schizophrenia. This often leads to further medical problems associated with obesity, as well as poor adherence to treatment.

      This drawback has become apparent with the introduction of new atypical antipsychotics; two drugs, clozapine and olanzapine, are known to induce substantial weight gain. Treatment with most other antipsychotics, both classic and atypical, produces some weight gain.

      The serotonin receptor 5-hydroxytryptamine 2C receptor (5-HT2C) has been associated with this effect. Investigators aimed to establish whether a genetic alteration of the promoter region of this receptor affects weight gain after drug treatment.

      Dr Reynolds and colleagues enrolled 123 Chinese in-patients with first-time schizophrenia. Patients received conventional treatment with antipsychotic drugs, in most cases chlorpromazine and risperidone, were given a standard hospital diet, and underwent blood testing to identify 5-HT2C receptor gene status.

      After six weeks, 28 percent of patients with the wild type (most common) genotype had an increased bodyweight of seven percent or more compared with none of the patients with the variant (-759T) allele. At 10 weeks, the corresponding proportions were 51 percent for the wild type genotype and 15 percent for the variant.

      Dr Reynolds in a separate comment on their study said: "We have identified a genetic factor that indicates the likelihood of developing a serious side effect of psychiatric drug treatment. If confirmed, these findings could provide the basis for a simple test to determine a patient's liability to develop drug-induced weight gain, and assist the doctor in choosing the most appropriate drug treatment.

      "Such predictive tests are likely to be common in the surgery of the future, where genetic profiling would be used to indicate the most effective and least harmful treatment, individualized for the patient."
      Lancet 2002; 359: 2086-87.

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send